EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lithium‐Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity

Antonio Buonerba iD, Giulia Puliatti iD, Domenica Donatella Li Puma iD, Bruno Bandiera iD, Beatrice Cannata iD, Maria Elena Marcocci iD, Nicolina Castagno, Irene Contento, Salvatore Impemba iD, Mariarosa Scognamiglio iD, Rocco Di Girolamo iD, Vincenzo Naddeo iD und 9 weitere

Advanced Materials · 2026-01 · 38 (3)

DOI: 10.1002/adma.202513858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 29.09.2025. Verfasst von Antonio Buonerba und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biology "Adolfo Zambelli", University of Salerno, Via Giovanni Paolo II, Fisciano, SA, 84084, Italy. Hauptthemen laut MEDLINE: Gold, Metal Nanoparticles, Lithium, Glycogen Synthase Kinase 3. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Association Research, Ministero dell'Università e della Ricerca - MUR, Finanziato dall'Unione europea-Next Generation EU, Missione 4, Componente 1-CUP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“A Trojan Horse for Lithium Delivery” . Lithium has important pharmacological applications, although its use is severely limited due to its narrow therapeutic window of administrable concentrations. This study presents a novel nanocarrier for this metal cation based on glutathione‐stabilized gold nanoparticles (LiG‐AuNPs), which enable targeted release of lithium. LiG‐AuNPs are easily synthesized, with dimensions of ≈2 nm, with a lithium loading of 2 wt%. These particles show a tendency to aggregate and a narrow size distribution. Aggregates of LiG‐AuNPs (a‐LiG‐AuNPs) are non‐toxic to cells at concentrations lower than 2 mg mL −1 and are rapidly internalized into cells, where they release lithium in the cytosol through cation exchange, effectively modulating Glycogen Synthase Kinase‐3 (GSK‐3β) activity, especially the β isoform. Administration of a‐LiG‐AuNPs in murine models increased the inhibitory phosphorylation of GSK‐3β at Ser9. Intranasal administration of a‐LiG‐AuNPs modulated GSK‐3β activity in the brain, particularly in the hippocampus, without significantly altering plasma lithium levels, even when the administration lasted several months. LiG‐AuNPs thus represent a powerful tool for the targeted administration of lithium, enhancing its therapeutic effects in modulating GSK‐3β. They have potential applications for treating illnesses depending on GSK‐3β (hyper)activation, such as mood disorders, Alzheimer's disease, and viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldMetal NanoparticlesLithiumGlycogen Synthase Kinase 3Drug CarriersAnimalsMiceGlycogen Synthase Kinase 3 betaHumansMalePhosphorylationGlutathione

Stichwörter der Autor:innen

Alzheimer's diseaseHSV‐1 infectionbipolar disorderglycogen synthase kinase 3gold nanoparticlelithium

Substanzen

GoldLithiumGlycogen Synthase Kinase 3 betaGlycogen Synthase Kinase 3Drug CarriersGlutathione

Autor:innen und Institutionen

  • Department of Chemistry and Biology "Adolfo Zambelli", University of Salerno, Via Giovanni Paolo II, Fisciano, SA, 84084, Italy.
  • Department of Neuroscience, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Rome, 00168, Italy.
  • Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo A. Gemelli 8, Rome, 00168, Italy.
  • Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, 00185, Italy.
  • Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, Fisciano, SA, 84084, Italy.
  • Department of Chemical Sciences, University of Naples Federico II, Via Cintia, 21, Naples, 80126, Italy.

ORCID-Profile: Antonio Buonerba, Giulia Puliatti, Domenica Donatella Li Puma, Bruno Bandiera, Beatrice Cannata, Maria Elena Marcocci, Salvatore Impemba, Mariarosa Scognamiglio, Rocco Di Girolamo, Vincenzo Naddeo, Patrizia Canton, Carmine Capacchione, Martina Albini, Alfonso Grassi, Claudio Grassi, Roberto Piacentini

Förderung

  • Alzheimer's Association Research
  • Ministero dell'Università e della Ricerca - MUR
  • Finanziato dall'Unione europea-Next Generation EU, Missione 4, Componente 1-CUP
  • Università degli Studi di Salerno

Zitieren

APA

Buonerba, A., Puliatti, G., Puma, D. D. L., Bandiera, B., Cannata, B., Marcocci, M. E., Castagno, N., Contento, I., Impemba, S., Scognamiglio, M., Girolamo, R. D., Naddeo, V., Canton, P., Capacchione, C., Sposito, L., Albini, M., Pastore, F., Baroni, S., Grassi, A., …, & Piacentini, R. (2026). Lithium‐Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity. Advanced Materials, 38(3). https://doi.org/10.1002/adma.202513858

Vancouver

Buonerba A, Puliatti G, Puma DDL, Bandiera B, Cannata B, Marcocci ME, et al. Lithium‐Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity. Advanced Materials. 2026;38(3). doi:10.1002/adma.202513858

BibTeX
@article{Buonerba2026,
  author = {Buonerba, Antonio and Puliatti, Giulia and Puma, Domenica Donatella Li and Bandiera, Bruno and Cannata, Beatrice and Marcocci, Maria Elena and Castagno, Nicolina and Contento, Irene and Impemba, Salvatore and Scognamiglio, Mariarosa and Girolamo, Rocco Di and Naddeo, Vincenzo and Canton, Patrizia and Capacchione, Carmine and Sposito, Laura and Albini, Martina and Pastore, Francesco and Baroni, Silvia and Grassi, Alfonso and Grassi, Claudio and Piacentini, Roberto},
  title = {Lithium‐Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {3},
  doi = {10.1002/adma.202513858}
}
Kostenlos starten →